[The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)].
D000284:Administration, Oral; D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004074:Digitoxin / Q000008:administration & dosage / Q000097:blood* / Q000378:metabolism; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000008:administration & dosage; D006801:Humans; D006900:Hydroxylation; D007408:Intestinal Absorption; D007538:Isoniazid / Q000008:administration & dosage; D007684:Kidney Tubules / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008875:Middle Aged; D011485:Protein Binding; D011863:Radioimmunoassay; D012293:Rifampin / Q000008:administration & dosage; D014376:Tuberculosis / Q000188:drug therapy
D000995:Antitubercular Agents; D004977:Ethambutol; D004074:Digitoxin; D007538:Isoniazid; D012293:Rifampin
Einfluss von Tuberkulostatika auf die Pharmakokinetik des Digitoxins